Butenafine topical Pregnancy Warnings
Animal studies have failed to reveal evidence of teratogenicity. There are no controlled data in human pregnancy.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
This drug should be used during pregnancy only if clearly needed.
US FDA pregnancy category: C
See references
Butenafine topical Breastfeeding Warnings
Caution is recommended.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments:
-This drug is not likely to reach the infant's bloodstream or to cause side effects in nursing infants due to poor absorption after topical administration.
-The infant's skin should not come into direct contact with skin that has been treated.
-Ointments should not be applied to the breast prior to breastfeeding; water miscible cream or gel products should be used if necessary.
See references
